Provisional CDC data project drug overdose deaths down 41 percent under President Trump from the Biden-era peak, a drop his drug policy chief says proves the strategy is working.
Breitbart News reported that the Centers for Disease Control and Prevention now predicts 66,478 provisional drug overdose deaths from May 2025 through May 2026. That figure stands against more than 112,400 drug overdose deaths under the Biden administration.
Officials described the 41 percent decline as the lowest predicted provisional estimate since January 2017, when former President Obama was leaving the White House. The numbers arrive as the Trump administration’s Office of National Drug Control Policy credits its National Drug Control Strategy for the turnaround.
National Drug Control Policy Director Sara Carter put the claim in plain terms.
"The continued decline in drug overdose deaths shows President Trump’s National Drug Control Strategy is working,"
Carter added a human measure of the same shift.
"There are over 45,000 Americans alive today because of the bold, decisive, and effective actions taken by this administration to defeat the scourge of illicit drugs,"
She closed with the standard the administration says it still intends to meet.
"Even in light of this historic progress, there is still much to be done, because the only acceptable number of overdose deaths is zero."
The reported declines stretch across major drug classes. Heroin overdose deaths decreased by more than 32 percent. Synthetic opioid deaths dropped by more than 19 percent. Overdose deaths from psychostimulants, including methamphetamine, declined by over 14 percent.
Natural and semi-synthetic opioid deaths fell nearly 7 percent. Cocaine deaths decreased almost 6 percent. Taken together, the category moves track the same provisional window the CDC used for the headline total.
Those synthetic opioid figures matter because fentanyl still drives so many fatal overdoses, including high-profile cases such as the coroner’s ruling on Hayden Panettiere’s accidental overdose involving fentanyl and other substances.
The Trump team frames the broader drop as proof that pressure on supply and trafficking can move national death counts. Specific statutes, raids, or border actions behind the percentages were not named in the available reporting. Carter’s statements rest on the strategy as a whole and on the CDC’s provisional projection.
The comparison point is stark. More than 112,400 drug overdose deaths under the Biden administration marked the peak against which the new provisional total is measured. The May 2025, May 2026 projection of 66,478 would reverse a large share of that loss of life in a single reporting window.
Families and campuses have continued to absorb the cost in the meantime. Recent coverage of two Ole Miss students found dead amid campus drugging fears underscored how quickly illicit drugs still reach young people far from the border.
Follow-on reporting noted that expedited toxicology in those Ole Miss deaths could open the door to fentanyl charges under Parker’s Law. The human stakes sit behind every percentage point in the CDC tables.
Carter’s “zero” goal leaves no victory lap. Illicit fentanyl and its chemical ingredients still move through international supply chains. The White House has previously pressed China for death sentences on illegal fentanyl chemical suppliers, a signal that precursor enforcement remains on the table.
Investigators have also kept pressure on domestic distribution networks, including cases where the DEA examined text messages with an alleged drug dealer tied to a fatal overdose. Street-level dealing and overseas chemistry both feed the same death toll the provisional data now show declining.
What the CDC projection does not settle is methodology detail. The precise Biden-era window behind the “more than 112,400” figure, the exact CDC table title, and the baseline used for each drug-class percentage were not spelled out beyond the totals and rates reported. Geography is treated as a national count. No city-level breakdown appears in the account.
Even so, the direction of the numbers is unambiguous in the material given: a projected 66,478 provisional deaths, a 41 percent drop from the prior peak, and the lowest such estimate since early 2017. Carter attributes the lives preserved, more than 45,000, by her count, to administration action against illicit drugs.
For readers who watched overdose deaths climb for years, the provisional reverse is the policy test that matters. Soft approaches and delayed enforcement left a higher body count on the books; the current figures move the other way.
Saving tens of thousands of Americans from overdose is the standard any serious drug policy should have to clear, and the one voters can measure in black and white.
